https://european-biotechnology.net/wp-content/uploads/2024/10/Mayo-Clinic_Gonda_building.jpg480640Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-30 11:53:272024-10-30 11:53:27AIgnostics raises US$34m in Series B financing
https://european-biotechnology.net/wp-content/uploads/2024/10/UCB_HQ_Brussels.jpeg294922Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-28 06:59:122024-10-28 06:59:12Cancer UK/UCB collaboration: study with 2nd compound started
https://european-biotechnology.net/wp-content/uploads/2024/10/agomab_HGF-Aktivatorprotein.jpg565848Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-25 09:10:082024-10-30 10:32:01Agomab raises US$89m in Series D
https://european-biotechnology.net/wp-content/uploads/2024/10/Rentschler-Biopharma_150516_0186_Nukleus.jpg540960Thomas Gabrielczyk/wp-content/uploads/2019/12/ebn-1-300x135.pngThomas Gabrielczyk2024-10-24 05:30:102024-10-24 05:30:10Rentschler with double-digit investment in Germany
